Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced a set of strategic ...
The biotech industry needs to stop waiting for a rebound. The pandemic changed everything, though not in the ways most people ...
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today provided an ...
The most common side effects of mRNA vaccines like the COVID-19 shot are well known: soreness, mild fever and general malaise ...
Aro Biotherapeutics, a clinical-stage biotechnology company developing potent and tissue-targeted short-interfering RNA (siRNA) medicines in areas of high unmet need in rare muscle diseases, ...
Karolinska ATMP Center, a collaboration between Karolinska Institutet and Karolinska University Hospital, is now opening a ...
Phase 2 Study Demonstrated 73% clinical Clearance in the 200-µg Arm suggests that ~3 out of 4 treated lesions may allow ...
COVID-19 vaccination during pregnancy may lower the risk for preeclampsia and other complications, according to new data.The findings “support the importance of strengthening COVID vaccination ...
The COVID-19 pandemic brought messenger RNA (mRNA) vaccines to the forefront of global health care. After their clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results